Former Goldman partner Joe Natauri seeks $850 million for PE fund – BNN Bloomberg

(Bloomberg) — Joe Natauri, a former Goldman Sachs Group Inc. partner who left to start her own private equity firm, has filed to raise as much as $850 million for her first fund named after the late Nobel laureate Marie Curie.

Invidia Curie Fund I LP is selling its shares to large institutional investors, according to a regulatory filing this week. The company has received some commitments and expects to complete fundraising next year, according to a person familiar with the matter.

Natauri’s Invidia Capital Management, which registered with the U.S. Securities and Exchange Commission in July, plans to focus on four areas of the North American healthcare sector: pharmaceutical outsourcing; consumer-driven healthcare; provider outsourcing services; and technology, according to registration.

“Healthcare is an attractive sector for investment,” Invidia said in a statement, citing “strong industry tailwinds, potential capital returns, acyclicality and historical growth independent of macroeconomic conditions.”

The number of new healthcare-focused private equity funds has fallen since 2021, when the buyout industry raised about $81 billion with the launch of 615 funds, according to Preqin. By contrast, private companies closed 249 health care funds last year, raising $61 billion. In the first 10 months of 2024, the industry raised about US$38 billion through 131 new funds.

Fortune previously reported on Invidia’s fundraising.

Natauri worked at Goldman for 17 years, most recently as global head of healthcare private equity. She left in December to form Invidia.

Curie was one of the Nobel Prize winners in physics in 1903—the first woman to receive the award—and received her second prize in chemistry eight years later.

(Updates with Preqin data in fifth paragraph.)